🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial

RecruitingPhase 2Ages any - anyAllCity of Hope Medical Center
NCT07650656 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This phase II trial compares standard of care surgical resection to fluorescence-guided surgical resection using indocyanine green and fluorescence imaging for reducing unexpected positive margin rates in patients with sarcoma. Surgical margins are one of the criteria used in assessing the effectiveness of a given surgical procedure. They are the edges or border of the tissue removed in cancer surgery. A negative margin means that the resected tumor is surrounded by normal tissue, which implies there is no disease left in the patient. By contrast, a positive margin means that sarcoma cells are visible at the edge of the tumor. Positive margins may be classified as planned when they are expected pre-operatively due to the preservation of a critical structure, or unexpected when the pathologist reports the presence of tumor at the margin despite the surgeon having intended to remove it in

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Documented written informed consent of the participant * Histologically confirmed diagnosis of intermediate to high grade sarcoma * All ages * Amenable to surgical resection as a part of curative intent for the patient * Willingness to: * Respond to surveys during the trial * Permit medical record/ clinical laboratory result review Exclusion Criteria: * Due for surgery with palliative intent * Recurrent tumors * Intracranial, retroperitoneal, and visceral anatomical locations * A woman of childbearing potential who is currently pregnant (as confirmed by urine pregnancy test) * A woman who are currently breastfeeding * Known allergies to ICG, iodine, iodine dyes or shellfish * Unable to provide written and informed consent * Patients with hyper-thyroidism or autonomic thyroid adenomas * Premature infants/neonates with exchange transfusion indication due to hyperbilirubinemia
💊

What it tests

  • Electronic Health Record Review
  • Fluorescence Imaging
  • Fluorescence-Guided Surgery
  • Indocyanine Green
  • Questionnaire Administration
📍

Where

1 site
City of Hope Medical Center
Duarte, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy